R Agah

453 total citations
22 papers, 373 citations indexed

About

R Agah is a scholar working on Immunology, Hematology and Epidemiology. According to data from OpenAlex, R Agah has authored 22 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 10 papers in Hematology and 3 papers in Epidemiology. Recurrent topics in R Agah's work include Immune Cell Function and Interaction (11 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Immunotherapy and Immune Responses (9 papers). R Agah is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Immunotherapy and Immune Responses (9 papers). R Agah collaborates with scholars based in United States and Italy. R Agah's co-authors include A Mazumder, A Mazumder, Andrew Sherrod, Asif Mazumder, Salvatore Benvenga, Roberto Vita, Amitabha Mazumder, Pamela Bean, Inderbir S. Gill and Fabrizio Guarneri and has published in prestigious journals such as Blood, The Journal of Immunology and Thyroid.

In The Last Decade

R Agah

21 papers receiving 359 citations

Peers

R Agah

IMMUN

HEMAT

ONCOL

EPIDE

PRM

Katsuo Yoshida Japan

JM Vossen Netherlands

C. O. Wu United States

H. Link Germany

M von Lilienfeld-Toal Germany

GC de Gast Netherlands

H. Ottinger Germany

B-M Svahn Sweden

Malek Aoudjhane France

Gerard J. Ventura United States

Katsuo Yoshida Japan

R Agah

172 ×0.8

IMMUN

84 ×0.6

HEMAT

70 ×0.7

ONCOL

48 ×0.7

EPIDE

41 ×0.9

PRM

Citations per year, relative to R Agah R Agah (= 1×) peers Katsuo Yoshida

Countries citing papers authored by R Agah

Since Specialization

Citations

This map shows the geographic impact of R Agah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Agah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Agah more than expected).

Fields of papers citing papers by R Agah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Agah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Agah. The network helps show where R Agah may publish in the future.

Co-authorship network of co-authors of R Agah

This figure shows the co-authorship network connecting the top 25 collaborators of R Agah. A scholar is included among the top collaborators of R Agah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Agah. R Agah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Agah, R, et al.. (2014). L-carnitine treatment in a seriously ill cancer patient with severe hyperthyroidism. HORMONES. 13(3). 407–412. 9 indexed citations

2.

Vita, Roberto, Fabrizio Guarneri, R Agah, & Salvatore Benvenga. (2013). Autoimmune Thyroid Disease Elicited by NY-ESO-1 Vaccination. Thyroid. 24(2). 390–394. 25 indexed citations

3.

Agah, R, et al.. (1996). Diffuse infiltrative lymphocytosis syndrome in a patient not infected with the human immunodeficiency virus.. PubMed. 164(3). 266–8. 3 indexed citations

4.

Agah, R, et al.. (1993). Granulocyte-macrophage colony-stimulating factor-induced antibody- dependent cellular cytotoxicity in bone marrow macrophages: application in bone marrow transplantation. Blood. 81(12). 3474–3479. 33 indexed citations

5.

Agah, R, et al.. (1993). Granulocyte-macrophage colony-stimulating factor-induced antibody- dependent cellular cytotoxicity in bone marrow macrophages: application in bone marrow transplantation. Blood. 81(12). 3474–3479. 2 indexed citations

6.

Bean, Pamela, et al.. (1992). Differential lysis of tumor target cells displayed by lymphokine activated killer (LAK) cell clones. The International Journal Of Cell Cloning. 10(3). 190–195. 1 indexed citations

7.

Agah, R, et al.. (1992). Synergism of interleukin-2 and cyclosporine A in induction of a graft- versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation. Blood. 80(1). 179–184. 16 indexed citations

8.

Agah, R, et al.. (1992). Synergism of interleukin-2 and cyclosporine A in induction of a graft- versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation. Blood. 80(1). 179–184. 17 indexed citations

9.

Charak, Bishan S., et al.. (1991). Interaction of various cytokines with interleukin 2 in the generation of killer cells from human bone marrow: Application in purging of leukemia. Leukemia Research. 15(9). 801–810. 14 indexed citations

10.

Agah, R, et al.. (1991). Adoptive transfer of anti-cytomegalovirus effect of interleukin-2- activated bone marrow: potential application in transplantation. Blood. 78(3). 720–727. 7 indexed citations

11.

Bean, Pamela, et al.. (1990). Heterogeneity of cell surface structures involved in cytotoxicity mediated by lymphokine activated killer cells.. PubMed. 9(1). 92–7. 5 indexed citations

12.

Agah, R, et al.. (1990). A novel approach to purging of leukemia by activation of bone marrow with interleukin 2.. PubMed. 6(3). 193–8. 24 indexed citations

13.

Watkins, Kristy, Susan Groshen, Shuo Chen, et al.. (1990). Phase I study of combination recombinant interleukin-2 and interferon gamma in patients with advanced malignancies.. PubMed. 2(2). 96–103. 2 indexed citations

14.

Agah, R & Amitabha Mazumder. (1989). The potential usefulness of interleukin-2 activated bone marrow cells as an active therapeutic tool against cytomegalovirus infection in a bone marrow transplantation setting. Journal of Clinical Immunology. 9(3). 223–228. 5 indexed citations

15.

Agah, R, et al.. (1989). Potent graft antitumor effect in natural killer-resistant disseminated tumors by transplantation of interleukin 2-activated syngeneic bone marrow in mice.. PubMed. 49(21). 5959–63. 22 indexed citations

16.

Agah, R, et al.. (1989). Generation and characterization of IL-2-activated bone marrow cells as a potent graft vs tumor effector in transplantation.. The Journal of Immunology. 143(9). 3093–3099. 38 indexed citations

17.

Agah, R, et al.. (1988). Therapy of disseminated NK-resistant tumor by the synergistic effects of recombinant interleukin-2 and tumor necrosis factor.. PubMed. 7(2). 140–51. 13 indexed citations

18.

Agah, R, et al.. (1988). Successful therapy of natural killer-resistant pulmonary metastases by the synergism of gamma-interferon with tumor necrosis factor and interleukin-2 in mice.. PubMed. 48(8). 2245–8. 42 indexed citations

19.

Agah, R, Hungyi Shau, & Amitabha Mazumder. (1987). Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populations. Cancer Immunology Immunotherapy. 24(3). 247–52. 7 indexed citations

20.

Agah, R. (1987). Respiratory Syncytial Virus (RSV) Infection Rate in Personnel Caring for Children With RSV Infections. American journal of diseases of children. 141(6). 695–695. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact